Specifications
| SKU | 0882022-CF |
| Alternate Names | Factor I; Fibrinogen from New Zealand sourced bovine plasma |
| Application Notes | Bovine fibrinogen has been used in studies of haemostatic therapy in surgical and massive trauma patients. These studies have shown that fibrinogen may prove to be more superior in stopping blood loss when compared to using fresh frozen plasma (FFP). It can be used for preparation of fibrin plates for analysis of fibrinolytic enzymes, a substrate for clotting assays, and study of fibrinogen degradation products. |
| Background_information | Fibrinogen is a blood protein that is involved in clotting and is converted to fibrin by thrombin. Fibrinogen has an approximate molecular weight of 340 kDa. It consists of three non-identical pairs of disulfidebonded chains. The α-chain has an approximate molecular weight of 63.5 kDa, the β-chain 56 kDa, and the γ-chain 47 kDa. At the amino termini, the three chains are connected in a dimeric disulfide knot (DSK). A second DSK occurs later in the molecule. Fibrinogen has approximately 4% carbohydrate content. |
| Base Catalog Number | 820221,820224,820225,820226 |
| Biochemical Physiological Actions | Fibrinogen is an acute phase protein that is part of the coagulation cascade of proteins. The end result of the cascade is the production of thrombin that converts fibrinogen to fibrin. Thrombin rapidly proteolyzes fibrinogen, releasing fibrinopeptide A. The loss of this small peptide is not sufficient to make the resulting fibrin molecule insoluble, but it tends to form complexes with adjacent fibrin and fibrinogen molecules. Thrombin then cleaves a second peptide, fibrinopeptide B, from fibrin and the fibrin monomers formed then polymerize spontaneously to form an insoluble gel. The polymerized fibrin is held together by noncovalent and electrostatic forces and stabilized by the transamidating enzyme, factor XIIIa, that is produced by the action of thrombin on factor XIII. The insoluble fibrin aggregates (clots) and aggregated platelets then block the damaged blood vessel and prevent further bleeding. The amount of fibrinogen in the plasma can serve as a nonspecific indicator of whether or not an inflammatory process is present in the body. Fibrinogen from any mammalian source will be cleaved by thrombin from any mammalian source. |
| CAS # | 9001-32-5 |
| Concentration | Protein: 70% w/w, balance excipients |
| EC Number | 232-598-6 |
| Format | Lyophilized powder |
| Grade | Analytical Grade |
| Host | Bovine |
| Molecular Weight | α-chain mol wt 63.5 kDa, β-chain mol wt 56 kDa, γ chain mol wt 47 kDa (about 4% carbohydrate content), soluble dimer mol wt 340 kDa (Lit.) |
| Personal Protective Equipment | Eyeshields, Gloves, respirator filter |
| pH | 6.4 (1% w/v in saline ) |
| Protein or Enzyme Type | Plasma & Blood Proteins |
| Solubility | Soluble in saline. Clear to slightly, hazy solution. |
| Source | New Zealand |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
Documents
Datasheet
Datasheet
![DS [0882022]](https://www.mpbio.com/static/version1750670430/frontend/Mpbio/default/en_US/images/document.png "DS [0882022]")
Brochures
Brochures
Powered by Bioz
